newsfilter
← Latest News
GlobeNewswire·

Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Promising preliminary Phase 2b (ASCEND) pancreatic cancer data (Cohort A) reported with Cohort B data anticipated in the coming months Enrollment completed in Qilu's Phase 2 trial evaluating certepetide for the